These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10728694)

  • 1. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
    Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
    Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma.
    Terakado N; Shintani S; Yano J; Chunnan L; Mihara M; Nakashiro K; Hamakawa H
    Oral Oncol; 2004 Apr; 40(4):383-9. PubMed ID: 14969817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
    Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor.
    Liang L; Hu D; Liu W; Williams JP; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S114-21. PubMed ID: 12902868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
    Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
    Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
    Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.
    Chinery R; Beauchamp RD; Shyr Y; Kirkland SC; Coffey RJ; Morrow JD
    Cancer Res; 1998 Jun; 58(11):2323-7. PubMed ID: 9622066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.